Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
DRUG PRODUCT COMPOSITIONS
Regulatory FDF Prices
NA
0
Weekly News Recap #Phispers


1. Gtpl9416
2. Isis396443
| Molecular Weight | 7127 g/mol |
|---|---|
| Molecular Formula | C234H340N61O128P17S17 |
| XLogP3 | -14.4 |
| Hydrogen Bond Donor Count | 40 |
| Hydrogen Bond Acceptor Count | 167 |
| Rotatable Bond Count | 176 |
| Exact Mass | 7124.2829700 g/mol |
| Monoisotopic Mass | 7122.2762603 g/mol |
| Topological Polar Surface Area | 2820 Ų |
| Heavy Atom Count | 457 |
| Formal Charge | 0 |
| Complexity | 19100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 72 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 43092
Submission : 2025-11-20
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42251
Submission : 2025-07-07
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41153
Submission : 2026-03-25
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41696
Submission : 2025-04-17
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41707
Submission : 2025-03-28
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 43283
Submission : 2025-12-26
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 43583
Submission : 2026-03-17
Status : Active
Type : II

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42326
Submission : 2025-08-05
Status : Active
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 71860-396
Start Marketing Date : 2016-12-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Transo-Pharm is a licensed distributor of pharmaceutical components for human and veterinary markets. The company supports the full API life cycle, from development to sales, and a...
About the Company : Aspen API is a cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. The company supplies a broad portfolio of over 50 high-qual...
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
About the Company : Pharmathen, established in 1969, has emerged as a leading in-house development partner in Europe. It specializes in the development, registration, manufacturing & life-cycle manage...
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
About the Company : Omgene Life Sciences Pvt. Ltd. is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integ...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...
About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuz...

About the Company : Sinopep leads the industry in therapeutic peptides, supplying top-demand APIs like Albuvirtide, Lanreotide, Semaglutide, and more. Renowned for high-quality peptide APIs and effici...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : SPINRAZA
Dosage Form : SOLUTION;INTRATHECAL
Dosage Strength : EQ 12MG BASE/5ML (EQ 2.4MG BASE/ML)
Approval Date : 2016-12-23
Application Number : 209531
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Brand Name : SPINRAZA
Dosage Form : SOLUTION;INTRATHECAL
Dosage Strength : EQ 28MG BASE/5ML (EQ 5.6MG BASE/ML)
Approval Date :
Application Number : 209531
RX/OTC/DISCN :
RLD :
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Brand Name : SPINRAZA
Dosage Form : SOLUTION;INTRATHECAL
Dosage Strength : EQ 50MG BASE/5ML (EQ 10MG BASE/ML)
Approval Date :
Application Number : 209531
RX/OTC/DISCN :
RLD :
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Solution For Injection
Dosage Strength : 12MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Packaging :
Regulatory Info : USA
Dosage : Solution For Injection
Dosage Strength : 12MG/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Greece
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Nusinersen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nusinersen manufacturer or Nusinersen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nusinersen manufacturer or Nusinersen supplier.
A Nusinersen Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nusinersen Sodium, including repackagers and relabelers. The FDA regulates Nusinersen Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nusinersen Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nusinersen Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Nusinersen Sodium supplier is an individual or a company that provides Nusinersen Sodium active pharmaceutical ingredient (API) or Nusinersen Sodium finished formulations upon request. The Nusinersen Sodium suppliers may include Nusinersen Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Nusinersen Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Nusinersen Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Nusinersen Sodium active pharmaceutical ingredient (API) in detail. Different forms of Nusinersen Sodium DMFs exist exist since differing nations have different regulations, such as Nusinersen Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nusinersen Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Nusinersen Sodium USDMF includes data on Nusinersen Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nusinersen Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nusinersen Sodium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nusinersen Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nusinersen Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nusinersen Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nusinersen Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nusinersen Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nusinersen Sodium suppliers with NDC on PharmaCompass.
Nusinersen Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nusinersen Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nusinersen Sodium GMP manufacturer or Nusinersen Sodium GMP API supplier for your needs.
A Nusinersen Sodium CoA (Certificate of Analysis) is a formal document that attests to Nusinersen Sodium's compliance with Nusinersen Sodium specifications and serves as a tool for batch-level quality control.
Nusinersen Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Nusinersen Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nusinersen Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Nusinersen Sodium EP), Nusinersen Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nusinersen Sodium USP).